# Cannabinoids as a Treatment for Insomnia in Major Depression

> **NCT05041647** · PHASE2 · COMPLETED · sponsor: **St. Joseph's Healthcare Hamilton** · enrollment: 14 (actual)

## Conditions studied

- Insomnia
- Depressive Disorder, Major
- Sleep Disorder
- Depression
- Insomnia Chronic

## Interventions

- **DRUG:** 25:1 CBD/THC
- **DRUG:** 5:1 CBD/THC
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05041647
- **Lead sponsor:** St. Joseph's Healthcare Hamilton
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-28
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2026-01-22

## Collaborators

- McMaster University

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05041647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05041647, "Cannabinoids as a Treatment for Insomnia in Major Depression". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05041647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*